Manufacturer record
Healer's Lab Unit II: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
24 batches manufactured by Healer's Lab Unit II (Himachal Pradesh) were declared Not of Standard Quality between June 2022 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
24 records linked to Healer's Lab Unit II in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 500 mg | PAK-825Mfg 2025-01 · Exp 2027-12 | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-677Mfg 2025-08 · Exp 2027-01 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-656Mfg 2025-08 · Exp 2027-01 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-629Mfg 2025-05 · Exp 2026-10 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-649Mfg 2025-05 · Exp 2026-10 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-628Mfg 2025-05 · Exp 2026-10 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Paracetamol Tablets IP 500mg | PAK-752Mfg 2024-07 · Exp 2027-06 | The sample does not conform to IP standards. It fails the test Dissolution and Description' mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab | Jun 2026 |
| Paracetamol Tablets IP 500mg | PAK-619Mfg 2024-01 · Exp 2026-12 | The sample does not conform to IP standards. It fails the test Dissolution and Description mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | PAK-643Mfg 2024-02 · Exp 2027-01 | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | PAK-628Mfg 2024-01 · Exp 2026-12 | It fails the test Dissolution as per IP as specified in the Laboratory Protocol.Dissolution | DTL, TVPMState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | PAK-557Mfg 2023-09 · Exp 2026-08 | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab | Jun 2026 |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | DMR-504Mfg 2026-01 · Exp 2027-12 | The sample does not conforms to the claim with respect to description as it show physical instability in the form of Mottling.Description | DTL, UdaipurState lab | Jun 2026 |
| Paracetamol Tablets IP 500mg | PTT-512Mfg 2025-04 · Exp 2028-03 | DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Paracetamol Tablets IP 500mg | PAK-634Mfg 2024-01 · Exp 2026-12 | Dissolution as per IPDissolution | RDTL, ErnakulamState lab | Mar 2026 |
| Vildagliptin Tablets IP 50mg | VGT505Mfg 2025-06 · Exp 2027-05 | ContentOther | DTL, Madurai-19State lab | Feb 2026 |
| Paracetamol Tablets IP 500mg | PAK-632Mfg 2024-01 · Exp 2026-12 | sample fails the test "Dissolution" as per IPDissolution | DTL ThrissurState lab | Jan 2026 |
| Aceclofenac & Paracetamol Tablets IP 100 mg /325 mg | APC-508Mfg 2024-07 · Exp 2026-06 | AssayAssay | SDTL Raipur ChhattisgarhState lab | Aug 2025 |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | LLP-511Mfg 2023-12 · Exp 2025-11 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Paracetamol Tablets IP 500 mg | PAK-517Mfg 2023-05 · Exp 2026-04 | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | PAK-558Mfg 2023-09 · Exp 2026-08 | It fails the test ?Dissolution? as per IP , as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | PAK-524Mfg 2023-05 · Exp 2026-04 | It fails the test ?Dissolution? as per IP specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | PAK 551Mfg 2023-06 · Exp 2026-05 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Feb 2025 |
| Rabeprazole Sodium Tablets I.P. | RBM-501Mfg 2022-04 · Exp 2024-03 | AssayAssay | CDTL MumbaiCDSCO lab | Nov 2022 |
| Albendazole Tablets I.P. | ALO-522Mfg 2021-01 · Exp 2022-12 | DescriptionDescription | CDL KolkataCDSCO lab | Jun 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.